Eosinophilia - 48 Studies Found Recruiting : Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric Patients : Eosinophilic Esophagitis Gastroesophageal Reflux : 2017-02-19 Completed : Data Bank for Eosinophilic Disorders : Eosinophilic Esophagitis Gastritis Enteritis : 2005-12-15 Terminated : Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin) : Drug Hypersensitivity : 2007-07-20 : Drug: Tegeline® 2g/kg in IV on 2days 2g/kg in IV on 4days for patients with renal insufficiency or Terminated : Effect of Hypertonic Solutions on Allergic Rhinitis Patients : Allergic Rhinitis : 2014-08-29 Not yet recruiting : Trial of Ketotifen in Children and Adolescents : Functional Dyspepsia : 2015-01-13 : Drug: Ketotifen Ketotifen is a Completed : A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma : Eosinophilic Asthma : 2011-01-25 : Drug: Reslizumab Patients were Completed : A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma : Eosinophilic Asthma : 2010-12-29 : Drug: Reslizumab 3.0 mg/kg or Terminated : Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma : Eosinophilic Asthma : 2011-02-04 : Drug: Reslizumab Reslizumab (3.0 mg/kg) administered intravenously by infusion every 28 days (±7 da Completed : A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma : Eosinophilic Asthma : 2011-01-28 : Drug: Reslizumab Patients were Completed : Usefulness of Exhaled NO in the Differential Diagnosis Acute Eosinophilic Pneumonia and Bacterial Pneumonia : Acute Eosinophilic Pneumonia : 2010-06-24 <<< Previous | Next >>>